A Prospective Nested Case-Control Study of Dengue in Infants: Rethinking and Refining the Antibody-Dependent Enhancement Dengue Hemorrhagic Fever Model
about
Epidemiological risk factors associated with high global frequency of inapparent dengue virus infectionsAn in-depth analysis of original antigenic sin in dengue virus infectionProtective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeysLong-Term Safety and Immunogenicity of a Tetravalent Live-Attenuated Dengue Vaccine and Evaluation of a Booster Dose Administered to Healthy Thai ChildrenCan non-human primates serve as models for investigating dengue disease pathogenesis?Epidemiology of dengue disease in the Philippines (2000-2011): a systematic literature reviewDengue viruses - an overviewThe Incidence, Characteristics, and Presentation of Dengue Virus Infections during InfancyClinical and Virological Features of Dengue in Vietnamese InfantsDengue: knowledge gaps, unmet needs, and research prioritiesProspects for a Zika Virus Vaccine.Low levels of antibody-dependent enhancement in vitro using viruses and plasma from dengue patients.Vertical Transmission of Dengue Virus in the Peripartum Period and Viral Kinetics in Newborns and Breast Milk: New Data.First experimental in vivo model of enhanced dengue disease severity through maternally acquired heterotypic dengue antibodiesCirculating levels of soluble MICB in infants with symptomatic primary dengue virus infections.Immune Response to Dengue Virus Infection in Pediatric Patients in New Delhi, India--Association of Viremia, Inflammatory Mediators and Monocytes with Disease Severity.Genome-wide expression profiling deciphers host responses altered during dengue shock syndrome and reveals the role of innate immunity in severe dengue.Dengue vaccines: state of the art.Development and characterization of a reverse genetic system for studying dengue virus serotype 3 strain variation and neutralization.Dengue virus infection-enhancing activity in serum samples with neutralizing activity as determined by using FcγR-expressing cells.Role of cognitive parameters in dengue hemorrhagic fever and dengue shock syndrome.Dengue vaccines: recent developments, ongoing challenges and current candidates.Dengue vaccine trial guidelines and role of large-scale, post proof-of-concept demonstration projects in bringing a dengue vaccine to use in dengue endemic areasAnti-dengue virus envelope protein domain III IgG ELISA among infants with primary dengue virus infectionsIdentification of a novel infection-enhancing epitope on dengue prM using a dengue cross-reacting monoclonal antibodyA birth cohort study of viral infections in Vietnamese infants and children: study design, methods and characteristics of the cohort.Toll-like receptor induced pro-interleukin-1β and interleukin-6 in monocytes are lower in healthy infants compared to adults.Neutralizing dengue antibody in pregnant Thai women and cord blood.Low adiposity during early infancy is associated with a low risk for developing dengue hemorrhagic fever: a preliminary model.Dengue epidemiology in selected endemic countries: factors influencing expansion factors as estimates of underreporting.Functionality of dengue virus specific memory T cell responses in individuals who were hospitalized or who had mild or subclinical dengue infectionComplexity of Neutralizing Antibodies against Multiple Dengue Virus Serotypes after Heterotypic Immunization and Secondary Infection Revealed by In-Depth Analysis of Cross-Reactive AntibodiesSevere dengue virus infection in pediatric travelers visiting friends and relatives after travel to the Caribbean.The Pattern of Adipose Tissue Accumulation during Early Infancy Provides an Environment for the Development of Dengue Hemorrhagic Fever.Epidemiology of Infant Dengue Cases Illuminates Serotype-Specificity in the Interaction between Immunity and Disease, and Changes in Transmission Dynamics.Meta-Analysis of Dengue Severity during Infection by Different Dengue Virus Serotypes in Primary and Secondary InfectionsNeutralizing antibody titers against dengue virus correlate with protection from symptomatic infection in a longitudinal cohort.Immunologic hypo- or non-responder in natural dengue virus infectionDengue viruses cluster antigenically but not as discrete serotypesAntibodies targeting dengue virus envelope domain III are not required for serotype-specific protection or prevention of enhancement in vivo
P2860
Q21131163-6D65F359-60C2-42C1-8348-32E1A5467B27Q24606493-3F778C1F-227C-4C4D-9378-0A024A454B44Q26248722-D149F1E1-5131-4FBF-8C48-5D666110E55EQ26314710-8B369CC2-FB92-455C-81C9-B80BFDC45D67Q26825708-F72D9591-39FE-4F6A-BD27-A5FE6EE19FE5Q26862715-5911FB92-868D-4A3B-9888-456D0B809921Q27026302-8808A498-E7A2-49AE-A5CE-3AA4A6E2538AQ27490855-F6EEE41E-D978-4B7A-88E4-015D0FF6844CQ27491351-3F1BC15A-723D-4250-8EC2-5554EA45C536Q28729764-1CEA29F2-4314-4BB4-92D7-18370E92A01EQ30235612-B494CC3E-71A3-4972-80A7-DD4BBB5E5A5FQ30392050-2D982E1D-4EBB-4DE1-AAB3-1E3F9785B158Q31137783-669AC815-095E-4C4F-B793-953738D0143CQ31156754-68DAB9CB-87A1-46A1-A949-1EFDA40E6DE7Q31161836-3385D4FA-6E71-40A2-AD53-BF8CD134096AQ33430763-13B9F35E-B798-420F-AA25-3BEA5180765AQ33638451-ACDF4BF7-A58F-4AD9-AD1F-77015460360AQ34109652-E1741F51-18A5-4393-8CFC-B33BFD6DD652Q34184711-C16621D4-21F3-4F85-96F5-7108AAAA1081Q34184747-CA714324-5713-49DD-94C4-0FF0DCB6AABCQ34242718-6FC6F099-F50E-48E8-85B0-30C33E1783EFQ34367194-81345076-A97B-4BEE-B619-233E4DC39C93Q34663993-4A56E530-D592-4DC7-A3B5-128272B28864Q34778121-3C308722-E896-4F99-9F98-9A88952CCFF6Q34976206-86D3B86F-DA2A-441D-B0F4-AC72B66ECE27Q35011189-789EC41B-BBE0-4AD7-98FF-AE936E84F701Q35035916-4AC26275-B4B6-4CD0-A3BF-6F3B4A28536AQ35058877-69501847-2407-48B4-8173-A652B58DADF4Q35095611-F780AF05-6726-4356-9437-AB2E5AA43B72Q35574035-D7EACEE1-390C-414D-9A9D-C9DFCBD1AAD5Q35601805-7582A532-2E4D-4D70-AE82-B3C3139A478FQ35758626-00F35ADC-6718-4339-9398-D793D654BED1Q35771812-D4498B1B-5806-4AC7-9B08-1D39B048D369Q35860915-8F05325B-A7E5-4A16-99E4-52D432823682Q35866928-880BD604-3870-4475-A9AC-6AC2D5D0653FQ36026358-995F2245-2CE7-40AC-B644-DB3502EDAEACQ36498207-2AC2BBE1-3ABA-46B6-B962-C3696B9A69DFQ36922684-3AB9F5B5-8EA6-4671-A213-88ACF3A6E64AQ36926525-25345A34-1DF8-488C-931B-F1F2F625CA29Q36931818-D855CA98-497F-43FE-8E05-930D54BDFBF9
P2860
A Prospective Nested Case-Control Study of Dengue in Infants: Rethinking and Refining the Antibody-Dependent Enhancement Dengue Hemorrhagic Fever Model
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
A Prospective Nested Case-Cont ...... Dengue Hemorrhagic Fever Model
@ast
A Prospective Nested Case-Cont ...... Dengue Hemorrhagic Fever Model
@en
A Prospective Nested Case-Cont ...... Dengue Hemorrhagic Fever Model
@nl
type
label
A Prospective Nested Case-Cont ...... Dengue Hemorrhagic Fever Model
@ast
A Prospective Nested Case-Cont ...... Dengue Hemorrhagic Fever Model
@en
A Prospective Nested Case-Cont ...... Dengue Hemorrhagic Fever Model
@nl
altLabel
A prospective nested case-cont ...... dengue hemorrhagic fever model
@en
prefLabel
A Prospective Nested Case-Cont ...... Dengue Hemorrhagic Fever Model
@ast
A Prospective Nested Case-Cont ...... Dengue Hemorrhagic Fever Model
@en
A Prospective Nested Case-Cont ...... Dengue Hemorrhagic Fever Model
@nl
P2093
P2860
P3181
P1433
P1476
A Prospective Nested Case-Cont ...... Dengue Hemorrhagic Fever Model
@en
P2093
Analisa Bautista
Daniel H Libraty
Edelwisa Segubre-Mercado
In-Kyu Yoon
James A Potts
Job D Brion
Luz P Acosta
Robert V Gibbons
Rosario Z Capeding
Veronica Tallo
P2860
P304
P3181
P356
10.1371/JOURNAL.PMED.1000171
P407
P5008
P577
2009-10-01T00:00:00Z